Christopher E. Gottfried focuses his practice on health care and FDA matters, as well as administrative and regulatory matters. Christopher represents clients such as pharmaceutical companies, clinical research organizations, nationwide pharmacies, cosmetic manufacturers and distributors, drug and cosmetic retailers, medical device manufacturers, drug and device distributors, large physician practice groups and hospital chains, compounding pharmacies, food manufacturers and distributors, ambulatory surgical centers, and home health agencies. He has experience working with numerous federal and state governmental agencies, and handles matters concerning fraud and abuse, drug and device development and regulation, clinical research, cosmetic product development and regulation, health care privacy including HIPAA, health care hospital and practitioner licensure and certificate of need, and various medical billing laws and regulations.
Christopher’s experience includes working with health care organizations to navigate the various clinical trial regulations from product inception through post-product marketing. Christopher has assisted various pharmaceutical, medical device, dietary supplements, and cosmetic manufacturers, distributors, and retailers in their clinical trial and regulatory matters.
Christopher also handles various regulatory matters for a wide range of health care entities. From data privacy and HIPAA to fraud and abuse, Christopher has assisted organizations of various sizes through complex health care regulatory schemes.
Prior to entering law, Christopher worked in research institutes both in the United States and abroad in cancer and internal medicine research.
Concentrations
•Health care fraud and abuse, including the Anti-Kickback Statute and Stark Law compliance
•Life Sciences
•Health care government investigations and defense
•Life Science, cosmetic, food, and health care transactions
•HIPAA and health privacy & security
•Life sciences, cosmetic, and food regulatory and compliance from product inception to retail
•FDA and MoCRA regulatory, compliance, and enforcement
•False Claims Act
•Life Sciences and health care private equity
Recognition & Leadership
Awards & Accolades
•Listed, The Best Lawyers in America, Ones to Watch,' Health Care Law, 2026